Shoji Hirokazu - Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 147 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Immune Checkpoint Inhibitors on Survival Outcomes in Advanced Gastric Cancer in Japan: A Real‐world Analysis

Toru Kadono,Satoru Iwasa,Toshiharu Hirose,Hidekazu Hirano,Natsuko Okita,Hirokazu Shoji,Atsuo Takashima,Ken Kato

CANCER MEDICINEno. 12 (2024)

引用0浏览0WOS引用

A Retrospective Analysis of the Prognostic Impact of KRAS G12D Mutation in Patients with RAS-mutated Metastatic Colorectal Cancer

Toshiharu Hirose,Kunihito Matsuguma,Hidekazu Hirano,Natsuko Tsuda Okita,Hirokazu Shoji,Atsuo Takashima,Ken Kato

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 105-105

引用0浏览0引用

Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics Database

Hiroyuki Fujii,Hidekazu Hirano,Kouya Shiraishi,Hirokazu Shoji,Toshiharu Hirose,Natsuko Okita,Atsuo Takashima,Takafumi Koyama,Ken Kato

JCO PRECISION ONCOLOGY（2024）

引用0浏览0WOS引用

Impact of Taxanes after PD-1 Blockade Exposure in Advanced Esophageal Squamous Cell Carcinoma

Kazuhiro Shiraishi, Yuki Takeyasu,Shun Yamamoto,Kotoe Oshima,Hiroshi Imazeki,Hidekazu Hirano,Natsuko Okita,Hirokazu Shoji,Yoshitaka Honma,Satoru Iwasa, Atsuo Takasima,Ken Kato

ESOPHAGUSno. 4 (2024): 539-545

引用0浏览0WOS引用

Retrospective Analysis of Definitive Chemoradiotherapy with FOLFOX in Patients with Esophageal Cancer Intolerant to Cisplatin

Mayu Yada,Shun Yamamoto,Yoshitaka Honma,Hidekazu Hirano,Natsuko Okita,Hirokazu Shoji,Satoru Iwasa,Atsuo Takashima,Akihito Nagahara,Ken Kato

IN VIVOno. 2 (2024): 761-766

引用0浏览0WOS引用

BRAF V600E-mutant Colorectal Cancer with CNS Metastases Treated Successfully with Encorafenib, Binimetinib and Cetuximab

Toru Imai,Hirokazu Shoji,Hidekazu Hirano,Kunihito Matsuguma, Takahito Awatsu,Toshiharu Hirose,Natsuko Okita,Atsuo Takashima,Ken Kato

CNS Oncologyno. 1 (2024)

引用0浏览0WOS引用

Effect of Phosphoproteomic Subtyping of Gastric Cancer on Chemotherapy and Guidance of Targeted Cancer Therapy

Hirokazu Shoji,Hidekazu Hirano,Yosui Nojima,Daigo Gunji, Akina Shinkura,Satoshi Muraoka,Yuichi Abe,Ryohei Narumi,Chioko Nagao,Masahiko Aoki,Kazutaka Obama,Kazufumi Honda,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Switching from FOLFIRI Plus Cetuximab to FOLFIRI Plus Bevacizumab Based on Early Tumor Shrinkage in RAS Wild-Type Metastatic Colorectal Cancer: A Phase II Trial (HYBRID)

Hiroyuki Arai,Takashi Tsuda,Yu Sunakawa,Mototsugu Shimokawa,Kohei Akiyoshi,Shinya Tokunaga,Hirokazu Shoji,Kenji Kunieda,Masahito Kotaka,Toshihiko Matsumoto,Yusuke Nagata,Takuro Mizukami,

CANCER MEDICINE（2024）

引用0浏览0WOS引用

Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma

Nozomu Ogura,Hidekazu Hirano,Kouya Shiraishi, Hiroyuki Fujii,Toshiharu Hirose,Hirokazu Shoji,Natsuko Tsuda Okita,Atsuo Takashima,Takafumi Koyama,Ken Kato

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 4-4

引用0浏览0引用

Preoperative Docetaxel, Cisplatin, and 5-Fluorouracil for Resectable Locally Advanced Esophageal and Esophagogastric Junctional Adenocarcinoma

Toshiharu Hirose,Shun Yamamoto,Yoshitaka Honma,Kazuki Yokoyama,Hidekazu Hirano,Natsuko Okita,Hirokazu Shoji,Satoru Iwasa,Atsuo Takashima,Koshiro Ishiyama,Junya Oguma,Hiroyuki Daiko,

ESOPHAGUSno. 3 (2024): 328-335

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn